Marek Spaczyński

2.2k citations

112 papers · 1.8k indexed · h-index 23

Impact in

Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
Oncology top 5%
- Drug Transport and Resistance Mechanisms

Papers in ⓘ

Oncology 30
- Cancer Risks and Factors 10
Epidemiology 29
- Cervical Cancer and HPV Research 23
- Hepatitis B Virus Studies 6

Co-authors: Ewa Nowak‐Markwitz (45 shared papers)M. Zabel (26 shared papers)Paweł Surowiak (21 shared papers)Hermann Lage (17 shared papers)Verena Materna (14 shared papers)Manfred Dietel (14 shared papers)Witold Kędzia (30 shared papers)Marta Szajnik (4 shared papers)
Journals: Journal of Clinical Oncology (3 papers)International Journal of Gynecological Cancer (3 papers)Clinical Cancer Research (2 papers)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (2 papers)Human Vaccines (2 papers)
Partner nations: Poland Germany United States

In The Last Decade

Marek Spaczyński

106 papers receiving 1.7k citations

Peers

Countries citing papers authored by Marek Spaczyński

Since Specialization

Citations

This map shows the geographic impact of Marek Spaczyński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Spaczyński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Spaczyński more than expected).

Fields of papers citing papers by Marek Spaczyński

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek Spaczyński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Spaczyński. The network helps show where Marek Spaczyński may publish in the future.

Co-authors

The 25 scholars most cited alongside Marek Spaczyński, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marek Spaczyński Line = papers co-authored together Marek Spaczyński links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer Oncogene ·Marta Szajnik, Mirosław J. Szczepański, Malgorzata Czystowska, Esther Elishaev, Magis Mandapathil, Ewa Nowak‐Markwitz, Marek Spaczyński, Theresa L. Whiteside	2009	199
2	Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15–55 years Vaccine ·Tino F. Schwarz, Marek Spaczyński, Achim Schneider, Jacek Wysocki, Andrzej Gałaj, Pamela Perona, Sylviane Poncelet, Toufik Zahaf, Karin Hardt, Dominique Descamps, Gary Dubin	2008	129
3	ABCC2 (MRP2, cMOAT) Can Be Localized in the Nuclear Membrane of Ovarian Carcinomas and Correlates with Resistance to Cisplatin and Clinical Outcome Clinical Cancer Research ·Paweł Surowiak, Verena Materna, Irina Kaplenko, Marek Spaczyński, Barbara Dolińska-Krajewska, Elżbieta Gębarowska, Manfred Dietel, M. Zabel, Hermann Lage	2006	87
4	Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Paweł Surowiak, Verena Materna, Irina Kaplenko, Marek Spaczyński, Manfred Dietel, Hermann Lage, M. Zabel	2005	82
5	Clinical Evidence for Topotecan-Paclitaxel Non–Cross-Resistance in Ovarian Cancer Journal of Clinical Oncology ·Martin Gore, W ten Bokkel Huinink, James Carmichael, Alan N. Gordon, Neville Davidson, Robert E. Coleman, Marek Spaczyński, Jean‐François Héron, Giorgio Bolis, Henric Malmström, John H. Malfetano, C Scarabelli, Phillipe Vennin, Graham Ross, Scott Z. Fields	2001	70
6	Nuclear metallothionein expression correlates with cisplatin resistance of ovarian cancer cells and poor clinical outcome Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Paweł Surowiak, Verena Materna, Adam Maciejczyk, Marek Pudełko, Ewa Markwitz, Marek Spaczyński, Manfred Dietel, M. Zabel, Hermann Lage	2007	66
7	Ten‐year immune persistence and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in females vaccinated at 15–55 years of age Cancer Medicine ·Tino F. Schwarz, Andrzej Gałaj, Marek Spaczyński, Jacek Wysocki, Andreas M. Kaufmann, Sylviane Poncelet, P.V. Suryakiran, Nicolas Folschweiller, Florence Thomas, Lan Lin, Frank Struyf	2017	58
8	CD46 expression is indicative of shorter revival-free survival for ovarian cancer patients. PubMed ·Paweł Surowiak, Verena Materna, Adam Maciejczyk, Irina Kaplenko, Marek Spaczyński, Manfred Dietel, Hermann Lage, M. Zabel	2007	53
9	Loss of estrogen receptor beta expression correlates with shorter overall survival and lack of clinical response to chemotherapy in ovarian cancer patients. PubMed ·Agnieszka Hałoń, Ewa Nowak‐Markwitz, Adam Maciejczyk, Marek Pudełko, Tserenchunt Gansukh, Balázs Győrffy, Piotr Donizy, Dawid Murawa, Rafał Matkowski, Marek Spaczyński, Hermann Lage, Paweł Surowiak	2011	47
10	Estrogen Receptor Alpha Expression in Ovarian Cancer Predicts Longer Overall Survival Pathology & Oncology Research ·Agnieszka Hałoń, Verena Materna, Małgorzata Drąg‐Zalesińska, Ewa Nowak‐Markwitz, Tserenchunt Gansukh, Piotr Donizy, Marek Spaczyński, M. Zabel, Manfred Dietel, Hermann Lage, Paweł Surowiak	2011	46
11	Expression of aminopeptidase N/CD13 in human ovarian cancers International Journal of Gynecological Cancer ·Paweł Surowiak, Marcin Drąg, Verena Materna, S Suchocki, Renata Grzywa, Marek Spaczyński, Manfred Dietel, Józef Oleksyszyn, M. Zabel, Hermann Lage	2006	41
12	Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy Fertility and Sterility ·Ewa Nowak‐Markwitz, Marcin Michalak, Mikołaj Olejnik, Marek Spaczyński	2008	40
13	Correlation between levels of human papillomavirus (HPV)-16 and 18 antibodies in serum and cervicovaginal secretions in girls and women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine Human Vaccines ·Tino F. Schwarz, Mariëlle Kocken, Tiina Petäjä, Mark H. Einstein, Marek Spaczyński, Jacqueline A. Louwers, Court Pedersen, Myron J. Levin, Toufik Zahaf, Sylviane Poncelet, Karin Hardt, Dominique Descamps, Gary Dubin	2010	38
14	Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial Contraception ·A. Teíchmann, Dan Apter, Janusz Emerich, Klaus Greven, Dagmara Klasa-Mazurkiewicz, G. B. Melis, Marek Spaczyński, Gary S. Grubb, Ginger D. Constantine, D. Spielmann	2009	36
15	Significance of cyclooxygenase 2 and MDR1/P-glycoprotein coexpression in ovarian cancers Cancer Letters ·Paweł Surowiak, Verena Materna, Carsten Denkert, Irina Kaplenko, Marek Spaczyński, Manfred Dietel, M. Zabel, Hermann Lage	2005	34
16	Persistence of immune response to HPV-16/18 AS04-adjuvanted cervical cancer vaccine in women aged 15-55 years Human Vaccines ·Tino F. Schwarz, Marek Spaczyński, Achim Schneider, Jacek Wysocki, Andrzej Gałaj, Karin Schulze, Sylviane Poncelet, Grégory Catteau, Florence Thomas, Dominique Descamps	2011	33
17	Paraneoplastic neurological syndromes associated with ovarian tumors Journal of Cancer Research and Clinical Oncology ·Mikołaj Piotr Zaborowski, Marek Spaczyński, Ewa Nowak‐Markwitz, S. Michalak	2014	30
18	Persistence of immune responses to the HPV‐16/18 AS04‐adjuvanted vaccine in women aged 15–55 years and first‐time modelling of antibody responses in mature women: results from an open‐label 6–year follow‐up study BJOG An International Journal of Obstetrics & Gynaecology ·Tino F. Schwarz, Marek Spaczyński, Andreas M. Kaufmann, Jacek Wysocki, Andrzej Gałaj, Karin Schulze, P.V. Suryakiran, Florence Thomas, Dominique Descamps	2014	29
19	Expression of factors involved in regulation of DNA mismatch repair- and apoptosis pathways in ovarian cancer patients Oncology Reports ·Verena Materna, Paweł Surowiak, Ewa Markwitz, Marek Spaczyński, Małgorzata Drąg‐Zalesińska, M. Zabel, Hermann Lage	2007	28
20	Effectiveness of gabapentin pharmacotherapy in chemotherapy-induced peripheral neuropathy Ginekologia Polska ·Magdalena Magnowska, Natalia Iżycka, Joanna Kapoła-Czyż, Anna Romała, Jakub Lorek, Marek Spaczyński, Ewa Nowak‐Markwitz	2018	27

About Marek Spaczyński

Marek Spaczyński is a scholar working on Oncology, Epidemiology, Reproductive Medicine, Molecular Biology and Public Health, Environmental and Occupational Health, having authored 112 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (23 papers), Ovarian cancer diagnosis and treatment (18 papers), Cancer Risks and Factors (10 papers), Estrogen and related hormone effects (7 papers), Hepatitis B Virus Studies (6 papers), Trace Elements in Health (5 papers), Nutrition and Health Studies (5 papers) and Endometrial and Cervical Cancer Treatments (4 papers). The work is most often cited by research in Reproductive Medicine (318 citations), Oncology (567 citations), Obstetrics and Gynecology (162 citations), Cancer Research (252 citations) and Immunology (299 citations). Marek Spaczyński has collaborated with scholars based in Poland, Germany and United States. Frequent co-authors include Ewa Nowak‐Markwitz, M. Zabel, Paweł Surowiak, Hermann Lage, Verena Materna, Manfred Dietel, Witold Kędzia, Marta Szajnik, Mirosław J. Szczepański and Tino F. Schwarz. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Gynecological Cancer, Clinical Cancer Research, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin and Human Vaccines.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact